Rioux Patrice's most recent trade in Monopar Therapeutics Inc was a trade of 1,380 Common Stock done at an average price of $0.0 . Disclosure was reported to the exchange on Aug. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 26 Aug 2026 | 1,380 | 5,066 (0%) | 0% | 0.0 | 7 | Common Stock |
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2026 | 1,380 | 0 | - | - | Stock Option | |
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 111.00 per share. | 26 Aug 2026 | 1 | 5,065 (0%) | 0% | 111 | 111 | Common Stock |
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 2,000 | 2,000 | - | - | Stock Option | |
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 2,000 | 2,000 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Rioux Patrice | Acting Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 10,000 | 10,000 | - | - | Stock Options |